Lessons Learned From the BEST-CLI and BASIL-2 Trials – American College of Cardiology
Mortality in patients with chronic limb threatening ischemia (CLTI) is high regardless of the revascularization strategy, so optimizing risk factor modification in this population is crucial to improve overall prognosis. The optimal treatment approach for CLTI varies depending on patients’ characteristics, comorbidities, anatomical considerations, and disease severities. An integrated, multidisciplinary approach is imperative to manage complex CLTI cases. Additional randomized trials integrating the